About Us
Leadership
Rajan Sah, MD, PhD
Senseion Co-Founder
and Chief Scientific Officer
Dr. Sah is an Associate Professor, Division of Cardiology, Washington University, St. Louis, Missouri. He is a Physician/scientist trained at University of Toronto; Weill Medical College of Cornell University; and Brigham and Women’s Hospital/Harvard University.
Dr. Sah, who discovered the metabolic pathways regulated by the novel target and defined the MOA and SAR for the Senseion SN-40X, is an inventor on the foundational patents.
Daniel J. Lerner, MD
Senseion Co-Founder
and Chief Executive Officer
Dr. Lerner has worked in successful life sciences companies for the past 15 years as Chief Medical Officer of TYRX™ (acquired by Medtronic), Co-founder of CV Ingenuity (acquired by Covidien), and Senior Vice President of Molecular Programs at FoxHollow (acquired by EV3). He received degrees in mechanical engineering and biological sciences from Stanford University, an completed medical school, residency, cardiology fellowship, and post-doctoral molecular medicine fellowship at the University of California, San Francisco (UCSF). Dr. Lerner is an inventor on patents for multiple drug/device combination products and an author on publications of both molecular and clinical investigations.
Scientific Advisory Board
David Clapham, MD, PhD
Senior Group Leader, Former Vice President & Chief Scientific Officer
Howard Hughes Medical Institute
C. Ronald Kahn, MD
Chief Academic Officer,
Joslin Diabetes Center
Mary K. Iacocca Professor of Medicine
Harvard Medical School
Marc Bonaca, MD, MPH
Executive Director CPC Clinical Research Director of Vascular Research
University of Colorado School of Medicine
Jorge Di Paola, MD
Chief & Elizabeth Finney McDonnell Professor Pediatric Hematology & Oncology
Washington University, St. Louis
Nathan O. Stitziel, MD, PhD
Director, Center for Cardiovascular Genetics
Departments of Medicine & Genetics
Washington University, St. Louis
Stephen Brohawn, PhD
Department of Molecular and Cellular Biology
Helen Wills Neuroscience Institute
University of California, Berkeley
Roland Dolle, PhD
Director of Chemistry
Center for Drug Discovery
Washington University, St. Louis